Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Impact of Arts-Based Interventions on Patient Hospital Experience

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04024670
Recruitment Status : Enrolling by invitation
First Posted : July 18, 2019
Last Update Posted : July 18, 2019
Sponsor:
Information provided by (Responsible Party):
Kimberly Kirklin, University of Alabama at Birmingham

Brief Summary:
nuts and bolts

Condition or disease Intervention/treatment Phase
High Risk Pregnancy Bone Marrow Other: Arts Intervention Not Applicable

Detailed Description:
interventions and timing of interventions

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Director, Arts in Medicine
Actual Study Start Date : January 1, 2019
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : July 1, 2020

Arm Intervention/treatment
Active Comparator: HRO
brief description do not too much
Other: Arts Intervention
If selected for the arts activity, an artist in residence will visit you 3 times a week for a total of 3 weeks during your hospital stay. Two visits will focus on the arts activity and one visit will be the administration of the questionnaire. Each visit will be approximately 25 minutes at a time.

Active Comparator: BMT Other: Arts Intervention
If selected for the arts activity, an artist in residence will visit you 3 times a week for a total of 3 weeks during your hospital stay. Two visits will focus on the arts activity and one visit will be the administration of the questionnaire. Each visit will be approximately 25 minutes at a time.

No Intervention: HRO Standard of Care
SOC
No Intervention: BMT Standard of Care
SOC



Primary Outcome Measures :
  1. Evaluate patient experience during the course of intervention using name of survey [ Time Frame: Baseline at admissions ]
    define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best

  2. Evaluate patient experience during the course of intervention using name of survey [ Time Frame: Baseline - end of week 1 ]
    define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best

  3. Evaluate patient experience during the course of intervention using name of survey [ Time Frame: week 1- week 2 ]
    define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best

  4. Evaluate patient experience during the course of intervention using name of survey [ Time Frame: week 2 - week 3 ]
    define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best

  5. Evaluate patient experience during the course of intervention using name of survey [ Time Frame: week 3 - weekly up to 10 weeks ]
    define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion:

  • Inpatient on either Bone Marrow Transplant ICU or High Risk Obstetrics Unit
  • Estimated length of stay 3-4 weeks
  • Age >18
  • Patients who will potentially benefit from the AIM experience

Additional Inclusion Criteria:

  • For the High Risk Obstetrics Unit group (hand-sewing), patients should be physically able to participate in hand-sewing activity.
  • For the Bone Marrow Transplant IUC group (story-telling/poetry), patients should be physically able to participate in story-telling/poetry activity.

Exclusion:

  • Patient too ill
  • Complex medical condition that requires therapies which would not allow time for participation
  • Declined to participate
  • Age <18

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04024670


Locations
Layout table for location information
United States, Alabama
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
Sponsors and Collaborators
University of Alabama at Birmingham

Layout table for additonal information
Responsible Party: Kimberly Kirklin, Principal Investigator, University of Alabama at Birmingham
ClinicalTrials.gov Identifier: NCT04024670     History of Changes
Other Study ID Numbers: IRB-300001347
First Posted: July 18, 2019    Key Record Dates
Last Update Posted: July 18, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Kimberly Kirklin, University of Alabama at Birmingham:
arts in medicine
sewing